Skip to content
DataLookout
Menu

NESICHNCT05539859

Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 2 years 9 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 1, 2025 to Jun 30, 2028 Show 6 more changesShow less
    • Eligibility criteria expanded, about 16 words
    • Trial status changed: Unknown → Recruiting
    • Study completion pushed from Sep 1, 2026 to Dec 31, 2028
    • Secondary endpoints: details revised at 11 of 16 entries
    • Site details revised at 2 of 4 sites
    • Publications: details revised at 7 of 7 entries
  2. Minor Changed Registry marked status Unknown; last known: Recruiting
  3. Notable Eligibility criteria shortened, about 287 words
    • Trial status: Recruiting to Unknown
    • Secondary endpoints: 17 to 16
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 4
    • Start date changed from estimate of Oct 1, 2022 to Nov 18, 2022
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

The proportion of patients with Modified Rankin Scale (mRS) score 0-3
Timeframe: 180 days
Safety outcome
Timeframe: 180 days

Secondary (8)

Glasgow Outcome Scale Extended (GOS-E)
Modified Rankin Scale (mRS) Score
Survival rate
Assessment of cognitive function with Mini-Mental State Examination (MMSE)
Quality of life measured with the 5-level EQ-5D (EQ-5D-5L)
Show 3 moreShow less
Length of ICU
Length of hospitalization
In-hospital cost

Arms and interventions

Experimental ArmExperimental

Endoscopic surgery

Control ArmActive comparator

Medical management

Procedures: Endoscopic surgery

Other: Medical management

Sites

4 sites in 1 country